Updates on EPC, PCT, EPO case law and the e-EQE

EP 3 167 888 B1 relates to the treatment of paroxysmal nocturnal hemoglobinuria patients with an inhibitor of complement component 5.
Claim 2 reads:
“A pharmaceutical composition comprising the antibody of claim 1.”
Claim 1 reads
“An antibody that binds C5 comprising a heavy chain consisting of SEQ ID NO: 2
and a light chain consisting of SEQ ID NO:4.”
According to the description SEQ ID NO: 2 represents the eculizumab heavy chain and SEQ ID NO:4 represents the eculizumab light chain.

EP 2 500 151 B1 relates to a machine and method for cartoning or packaging articles, in particular of articles with a tapered shape like the capsules, cups, etc.

Brief outline of the case
The OD had rejected the opposition and the opponent appealed.
The OD held that a prior use “Caffitaly”,

EP 1 856 792 B2 relates to a method for detecting the position of a rotor.

Brief outline of the case
The OD decided maintenance according to AR13 as claim 1 as granted lacked N over D12=AT 408 591, classified as Y,A in the ESR established by the EPO. The same applied to AR1.

EP 3 380 042 B1 relates to an assembly for replacing the tricuspid atrioventricular valve.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The board held that claim 1 as granted lacked IS over D5=US 2014/0194983, the first document classified X in the ISR established by the EPO.

EP 2 430 207 B1 relates to a process for manufacturing a coated metal plate having an improved appearance.

Brief outline of the case
Opponent I attacked 1 all claims and Opponent II only attacked claims 8-11.
The oppositions were rejected and both opponents appealed.
The bord decided maintenance according to AR1 filed in appeal.